350 related articles for article (PubMed ID: 28283268)
1. Perioperative management of vitamin K antagonists in patients with low thromboembolic risk undergoing elective surgery: A prospective experience.
Becerra AF; Cornavaca MT; Revigliono JI; Contreras A; Albertini R; Tabares AH
Med Clin (Barc); 2017 Oct; 149(7):281-286. PubMed ID: 28283268
[TBL] [Abstract][Full Text] [Related]
2. [Perioperative control of vitamin K antagonists in elective surgery].
Revigliono JI; Cornavaca T; Becerra F; Albertini R; Contreras AE; Tabares A
Medicina (B Aires); 2014; 74(5):385-90. PubMed ID: 25347900
[TBL] [Abstract][Full Text] [Related]
3. Bridging anticoagulation in patients treated with vitamin K antagonists prior to trochanteric and hip fracture surgeries: The current practice.
Szklanny K; Jakubek M; Zbierska-Rubinkiewicz K; Undas A
Adv Clin Exp Med; 2019 Apr; 28(4):469-477. PubMed ID: 30088350
[TBL] [Abstract][Full Text] [Related]
4. Incidence of venous thromboembolism and hemorrhage related safety studies of preoperative anticoagulation therapy in hip fracture patients undergoing surgical treatment: a case-control study.
Liu Z; Han N; Xu H; Fu Z; Zhang D; Wang T; Jiang B
BMC Musculoskelet Disord; 2016 Feb; 17():76. PubMed ID: 26873584
[TBL] [Abstract][Full Text] [Related]
5. Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates.
Siegal D; Yudin J; Kaatz S; Douketis JD; Lim W; Spyropoulos AC
Circulation; 2012 Sep; 126(13):1630-9. PubMed ID: 22912386
[TBL] [Abstract][Full Text] [Related]
6. Influence of periprocedural anticoagulation strategies on complication rate and hospital stay in patients undergoing catheter ablation for persistent atrial fibrillation.
Gunawardene M; Willems S; Schäffer B; Moser J; Akbulak RÖ; Jularic M; Eickholt C; Nührich J; Meyer C; Kuklik P; Sehner S; Czerner V; Hoffmann BA
Clin Res Cardiol; 2017 Jan; 106(1):38-48. PubMed ID: 27435077
[TBL] [Abstract][Full Text] [Related]
7. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen.
Douketis JD; Johnson JA; Turpie AG
Arch Intern Med; 2004 Jun; 164(12):1319-26. PubMed ID: 15226166
[TBL] [Abstract][Full Text] [Related]
8. [Bleeding risk and perioperative management of patients anticoagulated with vitamin K antagnosists].
Angelo M; Stockner I; Wiedermann CJ
Wien Med Wochenschr; 2008; 158(21-22):615-20. PubMed ID: 19052707
[TBL] [Abstract][Full Text] [Related]
9. Perioperative management of patients with antiphospholipid syndrome: a single-center experience.
Atisha-Fregoso Y; Espejo-Poox E; Carrillo-Maravilla E; Pulido-Ramírez AL; Lugo Baruqui D; Hernández-Molina G; Cabral AR
Rheumatol Int; 2017 Jul; 37(7):1159-1164. PubMed ID: 28474094
[TBL] [Abstract][Full Text] [Related]
10. The Perioperative Management of Antithrombotic Therapies Using Enoxaparin.
Hwang HG; Koo SM; Uh ST; Kim YK
J Korean Med Sci; 2017 Jun; 32(6):942-947. PubMed ID: 28480651
[TBL] [Abstract][Full Text] [Related]
11. Does antiplatelet therapy affect outcomes of patients receiving abdominal laparoscopic surgery? Lessons from more than 1,000 laparoscopic operations in a single tertiary referral hospital.
Fujikawa T; Tanaka A; Abe T; Yoshimoto Y; Tada S; Maekawa H; Shimoike N
J Am Coll Surg; 2013 Dec; 217(6):1044-53. PubMed ID: 24051069
[TBL] [Abstract][Full Text] [Related]
12. Bridging with enoxaparin using a half-therapeutic dose regimen: safety and efficacy.
Klamroth R; Gottstein S; Essers E; Landgraf H
Vasa; 2010 Aug; 39(3):243-8. PubMed ID: 20737383
[TBL] [Abstract][Full Text] [Related]
13. Perioperative Management of Antiplatelets and Anticoagulants Among Patients Undergoing Elective Transurethral Resection of the Prostate--A Single Institution Experience.
Ong WL; Koh TL; Fletcher J; Gruen R; Royce P
J Endourol; 2015 Nov; 29(11):1321-7. PubMed ID: 26154769
[TBL] [Abstract][Full Text] [Related]
14. Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an elective procedure or surgery.
Spyropoulos AC; Al-Badri A; Sherwood MW; Douketis JD
J Thromb Haemost; 2016 May; 14(5):875-85. PubMed ID: 26988871
[TBL] [Abstract][Full Text] [Related]
15. Predictors of oral cavity bleeding and clinical outcome after dental procedures in patients on vitamin K antagonists. A cohort study.
Biedermann JS; Rademacher WMH; Hazendonk HCAM; van Diermen DE; Leebeek FWG; Rozema FR; Kruip MJHA
Thromb Haemost; 2017 Jun; 117(7):1432-1439. PubMed ID: 28405671
[TBL] [Abstract][Full Text] [Related]
16. Management of periprocedural anticoagulant therapy: a novel individualized approach-a transeusophageal echocardiographic study.
Durmaz E; Karadag B; İkitimur B; Ebren C; Tokdil H; Koca D; Ozmen E; Polat F; Ohtaroglu Tokdil K; Raimoglu U; Mutlu D; Atici A; Ongen Z
J Thromb Thrombolysis; 2020 Aug; 50(2):408-415. PubMed ID: 32281070
[TBL] [Abstract][Full Text] [Related]
17. Standardized low-molecular-weight heparin bridging regimen in outpatients on oral anticoagulants undergoing invasive procedure or surgery: an inception cohort management study.
Pengo V; Cucchini U; Denas G; Erba N; Guazzaloca G; La Rosa L; De Micheli V; Testa S; Frontoni R; Prisco D; Nante G; Iliceto S;
Circulation; 2009 Jun; 119(22):2920-7. PubMed ID: 19470892
[TBL] [Abstract][Full Text] [Related]
18. [Perioperative Bridging with Enoxaparin. Results of the Prospective BRAVE Registry with 779 Patients].
Omran H; Hammerstingl C; Paar WD;
Med Klin (Munich); 2007 Oct; 102(10):809-15. PubMed ID: 17928964
[TBL] [Abstract][Full Text] [Related]
19. Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation.
Cappato R; Marchlinski FE; Hohnloser SH; Naccarelli GV; Xiang J; Wilber DJ; Ma CS; Hess S; Wells DS; Juang G; Vijgen J; Hügl BJ; Balasubramaniam R; De Chillou C; Davies DW; Fields LE; Natale A;
Eur Heart J; 2015 Jul; 36(28):1805-11. PubMed ID: 25975659
[TBL] [Abstract][Full Text] [Related]
20. Bleeding rates in patients older than 90 years of age on vitamin K antagonist therapy for nonvalvular atrial fibrillation.
Tincani E; Baldini P; Crowther MA; Zanasi A; Ferrari P; Cenci AM; Rioli G
Blood Coagul Fibrinolysis; 2009 Jan; 20(1):47-51. PubMed ID: 20523164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
